CD28 and type 2 diabetes mellitus: A study conducted by Phoksawat et al. (2016) reported that a subpopulation of IL-17-producing CD4+CD28-NKG2D+ T cells (identified as pathogenic CD4+ T cells) existed in the circulation of subjects with type 2 diabetes mellitus (T2DM) [17].